Literature DB >> 32885625

COVID-19 and tuberculosis co-infection: a neglected paradigm.

Arkapal Bandyopadhyay1, Sarika Palepu2, Krishna Bandyopadhyay3, Shailendra Handu4.   

Abstract

COVID-19 has been affecting mankind round the globe. The incidence of this infectious disease of respiratory origin is constantly on rise. Another infectious disease widely prevalent is tuberculosis (TB). During past corona virus pandemics of Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome, coinfection with TB was seen. We present this review as the co-infection of COVID-19 with TB has not been assessed yet, imposing a greater global threat. We suggest few measures to be implemented without delay for effectively screening the suspects of co-infection and also follow up of non-suspect patients in the post-pandemic phase.

Entities:  

Mesh:

Year:  2020        PMID: 32885625     DOI: 10.4081/monaldi.2020.1437

Source DB:  PubMed          Journal:  Monaldi Arch Chest Dis        ISSN: 1122-0643


  7 in total

1.  Microbial coinfections and superinfections in critical COVID-19: a Kenyan retrospective cohort analysis.

Authors:  Joe Rakiro; Jasmit Shah; Wangari Waweru-Siika; Ivy Wanyoike; Felix Riunga
Journal:  IJID Reg       Date:  2021-10-04

2.  Coinfections with Respiratory Pathogens among COVID-19 Patients in Korea.

Authors:  Kyoung Ho Roh; Yu Kyung Kim; Shin-Woo Kim; Eun-Rim Kang; Yong-Jin Yang; Sun-Kyung Jung; Sun-Hwa Lee; Nackmoon Sung
Journal:  Can J Infect Dis Med Microbiol       Date:  2021-05-12       Impact factor: 2.471

Review 3.  The role of co-infections and secondary infections in patients with COVID-19.

Authors:  Charles Feldman; Ronald Anderson
Journal:  Pneumonia (Nathan)       Date:  2021-04-25

4.  Tuberculosis amidst COVID-19 in Pakistan: a massive threat of overlapping crises for the fragile healthcare systems.

Authors:  Hashir Ali Awan; Abdul Moiz Sahito; Mahnoor Sukaina; Govinda Khatri; Summaiya Waheed; Fatima Sohail; Mohammad Mehedi Hasan
Journal:  Epidemiol Infect       Date:  2022-02-22       Impact factor: 2.451

5.  A co-infection model on TB - COVID-19 with optimal control and sensitivity analysis.

Authors:  Shraddha Ramdas Bandekar; Mini Ghosh
Journal:  Math Comput Simul       Date:  2022-04-16       Impact factor: 3.601

Review 6.  Mycobacterium tuberculosis and Pulmonary Rehabilitation: From Novel Pharmacotherapeutic Approaches to Management of Post-Tuberculosis Sequelae.

Authors:  Andreea-Daniela Meca; Liliana Mititelu-Tarțău; Maria Bogdan; Lorena Anda Dijmarescu; Ana-Maria Pelin; Liliana Georgeta Foia
Journal:  J Pers Med       Date:  2022-04-02

7.  Clinical features and outcomes of COVID-19 admissions in a population with a high prevalence of HIV and tuberculosis: a multicentre cohort study.

Authors:  Ayanda T Mnguni; Sean Wasserman; Arifa Parker; Linda Boloko; Muhammad S Moolla; Nabilah Ebrahim; Birhanu T Ayele; Alistair G B Broadhurst; Boitumelo Mashigo; Gideon Titus; Timothy de Wet; Nicholas Boliter; Michael-Jon Rosslee; Nectarios Papavarnavas; Riezaah Abrahams; Marc Mendelson; Sipho Dlamini; Jantjie J Taljaard; Hans W Prozesky; Abdurasiet Mowlana; Abraham J Viljoen; Neshaad Schrueder; Brian W Allwood; Usha Lalla; Joel A Dave; Greg Calligaro; Dion Levin; Deborah Maughan; Ntobeko A B Ntusi; Peter S Nyasulu; Graeme Meintjes; Coenraad F N Koegelenberg
Journal:  BMC Infect Dis       Date:  2022-06-20       Impact factor: 3.667

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.